ghmpns | 20759
MPN sequential testing (blood)
Keywords:
CALR Exon 9 Mutation
JAK2 Mutation Exon 12
JAK2 Mutation p.V617F
MPL p.W515 Mutation
Myeloproliferation
Myleoproliferative Neoplasm
Status
| Material |
|
||
|---|---|---|---|
| Hint |
JAK2 p.V617F Mutation > JAK2 Exon 12 Mutations > CALR Exon 9 Mutations > MPL p.W515 Mutation | To be determined within 24h from sampling. | There is a possibility of excess information occurring with this analysis. This will be communicated, unless it is noted otherwise when placing the order. | Since in rare cases there may also be indications of hereditary changes, the GUMG (Federal Law on Genetic Testing in Humans) provides for the patient to be informed accordingly (see www.viollier.ch/en/SGMG_consent). |
||
| Min. volume | 4 mL | ||
| Stability |
Stability
1 day / 18-25°C; 4 days / 2-8°C
|
||
| Duration | 5 days | ||
| Frequency | 2 x per week | ||
| Method | Next Generation Sequencing |
Price/Rate
| Price |
Price
CHF 954.90
|
|---|---|
| Rate |
Rate
954.90 TP
|
Single Analysis
| MPL p.W155 Mutations | ghmpl | Blood EDTA |
|---|---|---|
| CALR Exon 9 Mutations diagnostic | ghcal | Blood EDTA |
| JAK2 Exon 12 Mutations | jak2e | Blood EDTA |
| JAK2 p.V617F mutation diagnostic | jak2 | Blood EDTA |
